Femme et Homme
- | Pays :
- United Kingdom
- | Organes : -
- | Spécialités : -
Extrait
This study compared the pharmacokinetics, pharmacodynamics and the safety of Pegfilgrastim Hospira and Neulasta® following a single dose of 6 mg of each product administered subcutaneously in Treatment Periods 1 and 2, respectively, in healthy volunteers.
Critère d'inclusion
- Healthy